ACROBiosystems Opens France Hub at Villejuif Life Sciences Campus
Zurich – September 19, 2026 -- ACROBiosystems has established a dedicated office within The HIVE Innovation Center on Campus Grand Parc in Villejuif, deepening its footprint in France's oncology research corridor. The move, facilitated by real estate operator Kadans Science Partner, gives the roughly 1,000-employee biotechnology group direct proximity to biotechs, hospitals, and translational research institutes clustered around Paris-Saclay.
ACROBiosystems joins a biocluster it entered as a member last year
The company became a member of the Paris-Saclay Cancer Cluster (PSCC) in 2025, and the new HIVE office is positioned to extend those regional ties. Campus Grand Parc concentrates oncology-focused clinical partners and research teams, an environment ACROBiosystems says aligns with its role supplying reagents and services across the drug development chain -- from recombinant proteins and antibodies to GMP-grade custom production.